Alcon AG | ALC - Cost Of Sales



Alcon AG reported $1.21B in Cost of Sales for its fiscal quarter ending in June of 2025.


Cost Of Sales Change Date
AstraZeneca USD 2.47B 232M Jun/2025
Bayer EUR 4.36B 1.26B Jun/2025
Essilor EUR 5.31B 2.79B Jun/2025
Fresenius EUR 4.12B 117M Jun/2025
Fresenius Medical Care EUR 3.58B 120M Jun/2025
GlaxoSmithKline GBP 2.16B 241M Jun/2025
GRIFOLS EUR 1.15B 56.19M Jun/2025
Lonza CHF 2.47B 532M Dec/2024
Merck EUR 2.23B 93M Jun/2025
Novartis USD 3.32B 95M Jun/2025
Philips EUR 2.33B 79M Jun/2025
Roche Holding CHF 4.13B 393.5M Dec/2024
Sanofi EUR 2.99B 103M Jun/2025
Smith & Nephew USD 870M 41M Jun/2025
Sonova Holding CHF 514.8M 7M Sep/2024
UCB EUR 901M 50M Dec/2024